EP 2020850 A1 20090211 - NOVEL CANNABINOIDS AND METHODS OF USE
Title (en)
NOVEL CANNABINOIDS AND METHODS OF USE
Title (de)
NEUE CANNABINOIDE UND VERFAHREN ZU IHRER ANWENDUNG
Title (fr)
NOUVEAUX CANNABINOÏDES ET PROCÉDÉS D'UTILISATION
Publication
Application
Priority
- US 2007010474 W 20070501
- US 79614306 P 20060501
Abstract (en)
[origin: WO2007130361A1] Water- and lipid-soluble cannabinoid compounds that are agonists for CBl and CB2 receptors are provided. The cannabinoid compounds are useful for the treatment of retinal neurodegenerative disorders such as glaucoma, diabetic retinopathy and macular degeneration.
IPC 8 full level
A01N 43/02 (2006.01); A01N 43/00 (2006.01)
CPC (source: EP)
A61K 9/0048 (2013.01); A61P 9/10 (2017.12); A61P 25/02 (2017.12); A61P 27/02 (2017.12); A61P 27/06 (2017.12); A61P 43/00 (2017.12); C07D 231/12 (2013.01); C07D 233/61 (2013.01); C07D 249/08 (2013.01); C07D 295/145 (2013.01); C07D 311/80 (2013.01); C07D 405/06 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007130361 A1 20071115; AU 2007248760 A1 20071115; CA 2650900 A1 20071115; CN 101484004 A 20090715; EP 2020850 A1 20090211; EP 2020850 A4 20101013; JP 2009538827 A 20091112
DOCDB simple family (application)
US 2007010474 W 20070501; AU 2007248760 A 20070501; CA 2650900 A 20070501; CN 200780022510 A 20070501; EP 07794433 A 20070501; JP 2009509646 A 20070501